Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

The 2022 Tandem Meetings | Towards personalized therapy for chronic GvHD

Nataliya Buxbaum • 24 Apr 2022
The 2022 Tandem Meetings
General

Nataliya Buxbaum, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, comments on the importance of personalizing treatment for chronic graft-versus-host disease (cGvHD). In the past five years, three drugs have been approved by the FDA for GvHD. However, it is still necessary to determine which drug is best for each patient. This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.

More from Nataliya Buxbaum

St. Jude Children's Research Hospital & Roswell Park’s efforts to help pediatric patients in Ukraine
0:45
St. Jude Children's Research Hospital & Roswell Park’s efforts to help pediatric patients in Ukraine
Nataliya Buxbaum • 24 Apr 2022
T-cell metabolism: a novel therapeutic avenue for GvHD
1:23
T-cell metabolism: a novel therapeutic avenue for GvHD
Nataliya Buxbaum • 24 Apr 2022

Related Videos

Key principles for implementing AI tools into clinical practice
3:19
Key principles for implementing AI tools into clinical practice
Adrián Mosquera Orgueira • 24 Sep 2026
Current role of AI in hematology/oncology: separating the hype from reality
2:54
Current role of AI in hematology/oncology: separating the hype from reality
Adrián Mosquera Orgueira • 24 Sep 2026
Addressing the risk of over-reliance on AI for clinical decision-making
2:25
Addressing the risk of over-reliance on AI for clinical decision-making
Adrián Mosquera Orgueira • 24 Sep 2026
Telomere dynamics in normal and pathological aging
12:41
Telomere dynamics in normal and pathological aging
Coleman Lindsley • 18 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals